Weström S - Search Results

1

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, Capasso A, Pandzic T, Weström S, Foroughi-Asl H, Skaftason A, Gellerbring A, Lyander A, Gandini F, Gaidano G, Trentin L, Bonello L, Reda G, Bödör C, Stavroyianni N, Tam CS, Marasca R, Forconi F, Panayiotidis P, Ringshausen I, Jaksic O, Frustaci AM, Iyengar S, Coscia M, Mulligan SP, Ysebaert L, Strugov V, Pavlovsky C, Walewska R, Österborg A, Cortese D, Ranghetti P, Baliakas P, Stamatopoulos K, Scarfò L, Rosenquist R, Ghia P. Bonfiglio S, et al. Among authors: westrom s. Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821. Blood Adv. 2023. PMID: 36696464 Free PMC article.

2

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia.

Yaacov A, Lazarian G, Pandzic T, Weström S, Baliakas P, Imache S, Lefebvre V, Cymbalista F, Baran-Marszak F, Rosenberg S, Soussi T. Yaacov A, et al. Among authors: westrom s. Sci Rep. 2024 Sep 20;14(1):21962. doi: 10.1038/s41598-024-73027-1. Sci Rep. 2024. PMID: 39304718 Free PMC article.

3

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellström-Lindberg E. Tobiasson M, et al. Among authors: westrom s. J Clin Oncol. 2024 Apr 20;42(12):1378-1390. doi: 10.1200/JCO.23.01159. Epub 2024 Jan 17. J Clin Oncol. 2024. PMID: 38232336

4

Intraperitoneal alpha therapy with ²²⁴Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model.

Wouters R, Westrøm S, Berckmans Y, Riva M, Ceusters J, Bønsdorff TB, Vergote I, Coosemans A. Wouters R, et al. Among authors: westrom s. Front Med (Lausanne). 2022 Oct 10;9:995325. doi: 10.3389/fmed.2022.995325. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36300186 Free PMC article.

5

Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway.

Lampinen M, Hagforsen E, Weström S, Bergström A, Levedahl KH, Paivandy A, Lara-Valencia P, Pejler G, Rollman O. Lampinen M, et al. Among authors: westrom s. Exp Dermatol. 2022 Nov;31(11):1729-1740. doi: 10.1111/exd.14651. Epub 2022 Aug 4. Exp Dermatol. 2022. PMID: 35876458 Free PMC article.

6

Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays.

Chen L, Eriksson A, Weström S, Pandzic T, Lehmann S, Cavelier L, Landegren U. Chen L, et al. Among authors: westrom s. Nat Commun. 2022 Jul 12;13(1):4033. doi: 10.1038/s41467-022-31397-y. Nat Commun. 2022. PMID: 35821208 Free PMC article.

7

Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model.

Wouters R, Westrøm S, Vankerckhoven A, Thirion G, Ceusters J, Claes S, Schols D, Bønsdorff TB, Vergote I, Coosemans A. Wouters R, et al. Among authors: westrom s. Pharmaceutics. 2022 Mar 22;14(4):687. doi: 10.3390/pharmaceutics14040687. Pharmaceutics. 2022. PMID: 35456521 Free PMC article.

8

A Novel Single-Step-Labeled ²¹²Pb-CaCO₃ Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice.

Li RG, Lindland K, Bønsdorff TB, Westrøm S, Larsen RH. Li RG, et al. Among authors: westrom s. Materials (Basel). 2021 Nov 23;14(23):7130. doi: 10.3390/ma14237130. Materials (Basel). 2021. PMID: 34885283 Free PMC article.

9

Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation.

Jädersten M, Boriskina K, Lindholm C, Weström S, Cavelier L, Hellström-Lindberg E, Mielke S, Tobiasson M. Jädersten M, et al. Among authors: westrom s. Leuk Lymphoma. 2022 Mar;63(3):755-758. doi: 10.1080/10428194.2021.2002319. Epub 2021 Nov 15. Leuk Lymphoma. 2022. PMID: 34775885 No abstract available.

10

Exploration of novel candidate genes involved in epidermal keratinocyte differentiation and skin barrier repair in man.

Zhang H, Weström S, Kappelin P, Virtanen M, Vahlquist A, Törmä H. Zhang H, et al. Among authors: westrom s. Differentiation. 2021 May-Jun;119:19-27. doi: 10.1016/j.diff.2021.04.001. Epub 2021 Apr 30. Differentiation. 2021. PMID: 34029921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters